Advenchen Laboratories, LLC - Product Pipeline Review - 2013

Logo

Naperville, IL -- (SBWire) -- 08/08/2013 --Reportstack, provider of premium market research reports announces the addition of Advenchen Laboratories, LLC - Product Pipeline Review - 2013 market report to its offering
Advenchen Laboratories, LLC - Product Pipeline Review - 2013

Summary

pharmaceuticals report, Advenchen Laboratories, LLC - Product Pipeline Review - 2013 provides data on the Advenchen Laboratories, LLCs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Advenchen Laboratories, LLCs corporate website, SEC filings, investor presentations and featured press releases, both from Advenchen Laboratories, LLC and industry-specific third party sources, put together by team.

Scope

- Advenchen Laboratories, LLC - Brief Advenchen Laboratories, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Advenchen Laboratories, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Advenchen Laboratories, LLC with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Advenchen Laboratories, LLCs pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Advenchen Laboratories, LLCs strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Advenchen Laboratories, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Advenchen Laboratories, LLCs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Advenchen Laboratories, LLC.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Advenchen Laboratories, LLC and identify potential opportunities in those areas.

To view the table of contents for this market research report please visit
http://www.reportstack.com/product/138642/advenchen-laboratories-llc-product-pipeline-review-2013.html

Media Relations Contact

Roger Campbell
Director of Marketing
http://www.reportstack.com

View this press release online at: http://rwire.com/297398